Search - tctmd.com

Displaying 41 - 60 of 60

Sort: Relevancy | Date

News Features

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

Michael O'Riordan

April 07, 2020

News Opinion Editor's Corner

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

Shelley Wood

March 16, 2020

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Daily News

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Michael O'Riordan

December 06, 2018

Presentation TCT 2018

Sham Controls in Renal Denervation Studies: Need to Have vs Nice to Have?

Presenter: Kenneth J. Cavanaugh Jr, Roxana Mehran, David E. Kandzari

September 23, 2018

News Conference News TCT 2018

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Shelley Wood

September 17, 2018

News Daily News

New European Hypertension Guidelines Not in Harmony With US Guidance

Todd Neale

June 11, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2018

Caitlin E. Cox

June 01, 2018

News Conference News EuroPCR 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Shelley Wood

May 17, 2018

Presentation TCT 2017

Office, Home, or Ambulatory Blood Pressure: How to Measure Blood Pressure in Practice and Clinical Trials

Presenter: Sidney C. Smith, Michael A. Weber, C. Venkata S. Ram

October 30, 2017

Presentation TCT 2017

Recent Clinical Trials and Nonrandomized Studies That Will Change Your Daily Practice

Presenter: Sidney C. Smith, Michael A. Weber, Vasilios Papademetriou

October 30, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2017

Caitlin E. Cox

August 31, 2017

News Opinion Editor's Corner ESC 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Shelley Wood

August 18, 2017

Studies Supporting Device Modifications Weak, Often Based on Surrogate Endpoints

News Daily News

FDA Clearance of Modified Devices Relies Heavily on Weak Studies, Surrogate Endpoints

Michael O'Riordan

August 16, 2017

News Daily News

Event Rates Often Overestimated in Cardiovascular Trials

Yael L. Maxwell

June 10, 2015

News Conference News TCT 2013

Need, Potential Exist for Global Integrated Regulatory Approach in Cardiology

October 30, 2013

News Conference News TCT 2013

Innovation in Intervention: Perspectives from Industry

October 30, 2013

News Conference News AHA 2012

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

Jason Kahn

November 11, 2012

News Daily News

Un Modelo Sugiere que la Denervación Renal es Rentable contra la Hipertensión Resistente

September 13, 2012

News Daily News

Model Suggests Renal Denervation Cost-effective for Resistant Hypertension

September 13, 2012

Advertisement

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Sham Controls in Renal Denervation Studies: Need to Have vs Nice to Have?

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

New European Hypertension Guidelines Not in Harmony With US Guidance

TCTMD’s Top 10 Most Popular Stories for May 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Office, Home, or Ambulatory Blood Pressure: How to Measure Blood Pressure in Practice and Clinical Trials

Recent Clinical Trials and Nonrandomized Studies That Will Change Your Daily Practice

TCTMD’s Top 10 Most Popular Stories for August 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

FDA Clearance of Modified Devices Relies Heavily on Weak Studies, Surrogate Endpoints

Event Rates Often Overestimated in Cardiovascular Trials

Need, Potential Exist for Global Integrated Regulatory Approach in Cardiology

Innovation in Intervention: Perspectives from Industry

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

Un Modelo Sugiere que la Denervación Renal es Rentable contra la Hipertensión Resistente

Model Suggests Renal Denervation Cost-effective for Resistant Hypertension

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content